A 2026 real-world analysis presented in the oncology literature reported that GLP-1 receptor agonist exposure was associated with a modest reduction in breast cancer incidence among high-risk women with obesity
Participants received once-weekly semaglutide (initiated at 0.25 mg and gradually escalated to 2.0 mg) for 12 weeks, along with lifestyle intervention
The key is selecting a time that fits naturally into your weekly routine so you're unlikely to miss doses
Helps support energy production, exercise performance, and healthy weight management
Biological Support for Sustainable Weight Management Struggling with weight is rarely just a matter of willpower
"If you are increasing the protein, you're decreasing the rapidly absorbable carbohydrates, you're decreasing fat, excess calories, and sugar," says Kessler